Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 62 citing articles:

Pseudomonas aeruginosa: An Audacious Pathogen with an Adaptable Arsenal of Virulence Factors
Irene Jurado‐Martín, Maite Sainz-Mejías, Siobhán McClean
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 6, pp. 3128-3128
Open Access | Times Cited: 438
Pseudomonas aeruginosa in Chronic Lung Infections: How to Adapt Within the Host?
Emmanuel Faure, Kelly Kwong, Dao Nguyen
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 175
Pseudomonas aeruginosa elastase (LasB) as a therapeutic target
Martin Everett, David T. Davies
Drug Discovery Today (2021) Vol. 26, Iss. 9, pp. 2108-2123
Closed Access | Times Cited: 63
Lung epithelial cell–derived C3 protects against pneumonia-induced lung injury
Sanjaya Kumar Sahu, Ayşe Naz Ozantürk, Devesha H. Kulkarni, et al.
Science Immunology (2023) Vol. 8, Iss. 80
Open Access | Times Cited: 33
Quercetin: a promising virulence inhibitor of Pseudomonas aeruginosa LasB in vitro
Yanying Ren, Rui Zhu, Xiaojuan You, et al.
Applied Microbiology and Biotechnology (2024) Vol. 108, Iss. 1
Open Access | Times Cited: 14
Cathepsins in Bacteria-Macrophage Interaction: Defenders or Victims of Circumstance?
Lidia Szulc‐Dąbrowska, Magdalena Bossowska-Nowicka, Justyna Struzik, et al.
Frontiers in Cellular and Infection Microbiology (2020) Vol. 10
Open Access | Times Cited: 50
Pseudomonas aeruginosa in bronchiectasis: infection, inflammation, and therapies
Céline Vidaillac, Sanjay H. Chotirmall
Expert Review of Respiratory Medicine (2021) Vol. 15, Iss. 5, pp. 649-662
Closed Access | Times Cited: 42
Revisiting Host-Pathogen Interactions in Cystic Fibrosis Lungs in the Era of CFTR Modulators
Carla M. P. Ribeiro, Matthew G. Higgs, Marianne S. Muhlebach, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 5010-5010
Open Access | Times Cited: 22
Chemical Optimization of Selective Pseudomonas aeruginosa LasB Elastase Inhibitors and Their Impact on LasB-Mediated Activation of IL-1β in Cellular and Animal Infection Models
Martin Everett, David T. Davies, Simon Leiris, et al.
ACS Infectious Diseases (2023) Vol. 9, Iss. 2, pp. 270-282
Open Access | Times Cited: 13
The Pseudomonas aeruginosa protease LasB directly activates IL-1β
Josh Sun, Doris L. LaRock, Elaine A. Skowronski, et al.
EBioMedicine (2020) Vol. 60, pp. 102984-102984
Open Access | Times Cited: 38
The Yin and Yang of Streptococcus Lung Infections in Cystic Fibrosis: a Model for Studying Polymicrobial Interactions
Jessie E. Scott, George A. O’Toole
Journal of Bacteriology (2019) Vol. 201, Iss. 11
Open Access | Times Cited: 37
Emerging roles of the complement system in host–pathogen interactions
Sanjaya Kumar Sahu, Devesha H. Kulkarni, Ayşe Naz Ozantürk, et al.
Trends in Microbiology (2021) Vol. 30, Iss. 4, pp. 390-402
Open Access | Times Cited: 32
Pseudomonas aeruginosa Elastase Contributes to the Establishment of Chronic Lung Colonization and Modulates the Immune Response in a Murine Model
Cristina Cigana, Jérôme Castandet, Nicolas Sprynski, et al.
Frontiers in Microbiology (2021) Vol. 11
Open Access | Times Cited: 30
Pseudomonas aeruginosa and the Complement System: A Review of the Evasion Strategies
Àlex González-Alsina, Margalida Mateu-Borrás, Antonio Doménech‐Sánchez, et al.
Microorganisms (2023) Vol. 11, Iss. 3, pp. 664-664
Open Access | Times Cited: 11
Intrapulmonary-administered myeloid derived suppressor cells rescue mice from Pseudomonas aeruginosa infection and promote a regulatory/repair phenotype
Maëlys Born-Bony, Clémentine Cornu, Bérengère Villeret, et al.
Mucosal Immunology (2025)
Open Access
Interplay between host-microbe and microbe-microbe interactions in cystic fibrosis
Catherine R. Armbruster, Tom Coenye, Lhousseine Touqui, et al.
Journal of Cystic Fibrosis (2019) Vol. 19, pp. S47-S53
Open Access | Times Cited: 31
Exoproteomics for Better Understanding Pseudomonas aeruginosa Virulence
Salomé Sauvage, Julie Hardouin
Toxins (2020) Vol. 12, Iss. 9, pp. 571-571
Open Access | Times Cited: 30
Molecular Analysis of the Contribution of Alkaline Protease A and Elastase B to the Virulence of Pseudomonas aeruginosa Bloodstream Infections
Margalida Mateu-Borrás, Laura Zamorano, Àlex González-Alsina, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 11
Open Access | Times Cited: 17
Exploring the Antimicrobial Potential of Chitosan Nanoparticles: Synthesis, Characterization and Impact on Pseudomonas aeruginosa Virulence Factors
Dominik Maršík, Olga Maťátková, Anna Kolková, et al.
Nanoscale Advances (2024) Vol. 6, Iss. 12, pp. 3093-3105
Open Access | Times Cited: 3
Out-Smarting the Host: Bacteria Maneuvering the Immune Response to Favor Their Survival
Nastaran Mues, Hong Wei Chu
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 26
Bacterial behavior in human blood reveals complement evaders with some persister-like features
Stéphane Pont, Nathan Fraikin, Yvan Caspar, et al.
PLoS Pathogens (2020) Vol. 16, Iss. 12, pp. e1008893-e1008893
Open Access | Times Cited: 26
Influenza A Virus Pre-Infection Exacerbates Pseudomonas aeruginosa-Mediated Lung Damage Through Increased MMP-9 Expression, Decreased Elafin Production and Tissue Resilience
Bérengère Villeret, Brigitte Solhonne, Marjolène Straube, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 24
Plumbagin inhibits quorum sensing-regulated virulence and biofilms of Gram-negative bacteria:in vitroandin silicoinvestigations
Faizan Abul Qais, Mohammad Shavez Khan, Iqbal Ahmad, et al.
Biofouling (2021) Vol. 37, Iss. 7, pp. 724-739
Open Access | Times Cited: 23
Structure-Based Design of α-Substituted Mercaptoacetamides as Inhibitors of the Virulence Factor LasB from Pseudomonas aeruginosa
Cansu Kaya, Isabell Walter, Alaa Alhayek, et al.
ACS Infectious Diseases (2022) Vol. 8, Iss. 5, pp. 1010-1021
Open Access | Times Cited: 16
Overview of CF lung pathophysiology
Giulio Cabrini, Alessandro Rimessi, Monica Borgatti, et al.
Current Opinion in Pharmacology (2022) Vol. 64, pp. 102214-102214
Closed Access | Times Cited: 15
Page 1 - Next Page

Scroll to top